Total Payments
$844.84
2023 Payments
$215.84
Companies
10
Transactions
53
Medicare Patients
1,797
Medicare Billing
$203,144
Payment Breakdown by Category
Food & Beverage$844.84 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $844.84 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $359.50 | 17 | $0 (2023) |
| Allergan Inc. | $287.69 | 23 | $0 (2018) |
| PFIZER INC. | $47.07 | 3 | $0 (2017) |
| Novo Nordisk Inc | $33.66 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $33.51 | 3 | $0 (2019) |
| Amgen Inc. | $22.22 | 1 | $0 (2017) |
| AbbVie, Inc. | $20.57 | 1 | $0 (2018) |
| GE Healthcare | $16.90 | 1 | $0 (2018) |
| Apria Healthcare LLC | $12.54 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11.18 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $215.84 | 2 | GlaxoSmithKline, LLC. ($215.84) |
| 2021 | $12.54 | 1 | Apria Healthcare LLC ($12.54) |
| 2019 | $11.01 | 1 | Merck Sharp & Dohme Corporation ($11.01) |
| 2018 | $200.96 | 13 | Allergan Inc. ($109.64) |
| 2017 | $404.49 | 36 | Allergan Inc. ($178.05) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $114.21 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $101.63 | General |
| 03/03/2021 | Apria Healthcare LLC | Medela (Device), Philips, Invacare | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Wound care NPWT pump | ||||||
| 01/17/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/28/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, JANUMET XR | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/16/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2018 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Endocrinology | ||||||
| 09/25/2018 | GE Healthcare | — | Food and Beverage | Cash or cash equivalent | $16.90 | General |
| 07/23/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/12/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/17/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2017 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug), BREO | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $0.39 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2017 | Allergan Inc. | SAPHRIS (Drug), VRAYLAR | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 17 | $3,264 | $1,189 |
| 2022 | 1 | 12 | 16 | $3,072 | $1,530 |
| 2021 | 8 | 506 | 2,108 | $96,809 | $53,128 |
| 2020 | 15 | 1,266 | 6,481 | $269,827 | $147,296 |
Total Patients
1,797
Total Services
8,622
Medicare Billing
$203,144
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 17 | $3,264 | $1,189 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 16 | $3,072 | $1,530 | 49.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 26 | 1,560 | $39,936 | $23,945 | 60.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 139 | 139 | $28,957 | $18,577 | 64.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 73 | $13,490 | $5,273 | 39.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 56 | $7,174 | $2,668 | 37.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 49 | 56 | $3,881 | $1,601 | 41.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 138 | 179 | $1,271 | $534.60 | 42.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 27 | 31 | $1,497 | $320.88 | 21.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 14 | $603.40 | $208.84 | 34.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 58 | 5,101 | $127,584 | $77,556 | 60.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 339 | 339 | $69,666 | $39,936 | 57.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 133 | 155 | $28,063 | $9,903 | 35.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 110 | 131 | $16,372 | $4,990 | 30.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 22 | 22 | $5,484 | $3,725 | 67.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 43 | 48 | $3,284 | $2,430 | 74.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 23 | 23 | $6,726 | $2,328 | 34.6% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 46 | 46 | $1,932 | $1,932 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 74 | 76 | $1,900 | $1,283 | 67.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 64 | 102 | $4,814 | $1,135 | 23.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 278 | 362 | $2,527 | $1,077 | 42.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 22 | 22 | $925.10 | $645.93 | 69.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 14 | 14 | $386.40 | $233.88 | 60.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 29 | 29 | $97.00 | $96.50 | 99.5% |
| 81003 | Automated urinalysis test | Office | 2020 | 11 | 11 | $66.40 | $24.45 | 36.8% |
About Dr. Anca Voinov, MD
Dr. Anca Voinov, MD is a Family Medicine healthcare provider based in Largo, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700099819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anca Voinov, MD has received a total of $844.84 in payments from pharmaceutical and medical device companies, with $215.84 received in 2023. These payments were reported across 53 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($844.84).
As a Medicare-enrolled provider, Voinov has provided services to 1,797 Medicare beneficiaries, totaling 8,622 services with total Medicare billing of $203,144. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Largo, FL
- Active Since 05/07/2007
- Last Updated 08/25/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700099819
Products in Payments
- AREXVY (Drug) $114.21
- BREO (Drug) $76.94
- VIBERZI (Drug) $74.92
- VRAYLAR (Drug) $65.33
- LINZESS (Drug) $56.42
- BYSTOLIC (Drug) $47.51
- INCRUSE (Drug) $35.37
- JANUVIA (Drug) $33.51
- TRELEGY ELLIPTA (Drug) $31.35
- VIAGRA (Drug) $30.25
- Tresiba (Drug) $22.28
- Prolia (Biological) $22.22
- Synthroid (Drug) $20.57
- EUCRISA (Drug) $16.82
- SAPHRIS (Drug) $16.67
- NAMZARIC (Drug) $15.99
- Medela (Device) $12.54
- Levemir (Drug) $11.38
- JARDIANCE (Drug) $11.18
- BYVALSON (Drug) $10.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Largo
Dr. Ginger Urbaniak, M.d, M.D
Family Medicine — Payments: $10,464
Family Medicine $10,464
Mr. Gerald Fitzgerald, D.o, D.O
Family Medicine — Payments: $8,261
Family Medicine $8,261
Kirsten Cooper, M.d, M.D
Family Medicine — Payments: $6,017
Family Medicine $6,017
Dr. Jorge Figueroa, Md, MD
Family Medicine — Payments: $5,451
Family Medicine $5,451
Rafael Velasquez, Md, MD
Family Medicine — Payments: $4,648
Family Medicine $4,648
Dr. Mira Mahajan, Md, MD
Family Medicine — Payments: $4,497
Family Medicine $4,497